These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 14500190)

  • 1. Argatroban for off-pump coronary artery bypass surgery.
    Nielsen VG
    Anesth Analg; 2003 Oct; 97(4):1201-1202. PubMed ID: 14500190
    [No Abstract]   [Full Text] [Related]  

  • 2. Hemostatic analysis of a patient undergoing off-pump coronary artery bypass surgery with argatroban anticoagulation.
    Kieta DR; McCammon AT; Holman WL; Nielsen VG
    Anesth Analg; 2003 Apr; 96(4):956-958. PubMed ID: 12651640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Anticoagulation].
    Pötzsch B
    Med Klin Intensivmed Notfmed; 2013 May; 108(4):325-34; quiz 335-6. PubMed ID: 23625324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct thrombin and factor Xa inhibitors in children: a quest for new anticoagulants for children.
    Streif W; Ageno W
    Wien Med Wochenschr; 2011 Feb; 161(3-4):73-9. PubMed ID: 21404143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticoagulation in children: Making the most of little patients and little evidence.
    Young G; Male C; van Ommen CH
    Blood Cells Mol Dis; 2017 Sep; 67():48-53. PubMed ID: 28552476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bivalirudin as alternative to both danaparoid and heparin in off-pump coronary artery bypass grafting.
    Baciewicz FA
    J Thorac Cardiovasc Surg; 2003 Dec; 126(6):2108-9; author reply 2109. PubMed ID: 14688746
    [No Abstract]   [Full Text] [Related]  

  • 7. Antithrombin deficiency in special clinical syndromes--Part II: cardiovascular surgery.
    Levy JH
    Semin Hematol; 1995 Oct; 32(4 Suppl 2):49-55. PubMed ID: 8821210
    [No Abstract]   [Full Text] [Related]  

  • 8. Bivalirudin (Angiomax) for angioplasty.
    Med Lett Drugs Ther; 2001 Apr; 43(1103):37-8. PubMed ID: 11331441
    [No Abstract]   [Full Text] [Related]  

  • 9. Publication policy, informed consent, and the randomized clinical trial.
    Califf RM
    Am Heart J; 2002 Feb; 143(2):187-8. PubMed ID: 11835017
    [No Abstract]   [Full Text] [Related]  

  • 10. Argatroban, a new treatment option for heparin-induced thrombocytopenia.
    Cleveland KW
    Crit Care Nurse; 2003 Dec; 23(6):61-6. PubMed ID: 14692173
    [No Abstract]   [Full Text] [Related]  

  • 11. Improved efficacy and less bleeding: further evidence of a unique uncoupling of benefit and risk with bivalirudin.
    White HD
    Am Heart J; 2002 Feb; 143(2):189-92. PubMed ID: 11835018
    [No Abstract]   [Full Text] [Related]  

  • 12. Failure of argatroban anticoagulation during off-pump coronary artery bypass surgery.
    Cannon MA; Butterworth J; Riley RD; Hyland JM
    Ann Thorac Surg; 2004 Feb; 77(2):711-3. PubMed ID: 14759471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FDA panel votes against approval for bivalirudin.
    Piña I
    Circulation; 1999 Mar; 99(10):1277. PubMed ID: 10077507
    [No Abstract]   [Full Text] [Related]  

  • 14. Bivalirudin, a bivalent, thrombin specific anticoagulant as an alternative to heparin in interventional procedures as an alternative to heparin in interventional procedures.
    Chew DP
    Hamostaseologie; 2002 Aug; 22(3):60-6. PubMed ID: 12215763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bivalirudin in acute coronary syndromes.
    Sanmartin M
    N Engl J Med; 2007 Mar; 356(10):1069-70; author reply 1070-1. PubMed ID: 17347463
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of bivalirudin and argatroban for the management of heparin-induced thrombocytopenia.
    Skrupky LP; Smith JR; Deal EN; Arnold H; Hollands JM; Martinez EJ; Micek ST
    Pharmacotherapy; 2010 Dec; 30(12):1229-38. PubMed ID: 21114390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safe and efficacious use of bivalirudin for percutaneous coronary intervention with adjunctive platelet glycoprotein IIb/IIIa receptor inhibition.
    Cho L; Chew DP; Moliterno DJ; Roffi M; Ellis SG; Franco I; Bajzer C; Bhatt DL; Dorosti K; Simpfendorder C; Tuzcu M; Yadav JS; Brener S; Raymond R; Whitlow P; Topol EJ; Lincoff AM
    Am J Cardiol; 2003 Mar; 91(6):742-3. PubMed ID: 12633814
    [No Abstract]   [Full Text] [Related]  

  • 18. Caspofungin acetate, bivalirudin.
    Am J Health Syst Pharm; 2001 Oct; 58(19):1807-9. PubMed ID: 11596694
    [No Abstract]   [Full Text] [Related]  

  • 19. Thrombin, an ideal target for pharmacological inhibition: a review of direct thrombin inhibitors.
    Gurm HS; Bhatt DL
    Am Heart J; 2005 Jan; 149(1 Suppl):S43-53. PubMed ID: 15644793
    [No Abstract]   [Full Text] [Related]  

  • 20. Bivalirudin resistance in a patient on veno-venous extracorporeal membrane oxygenation with a therapeutic response to argatroban.
    Berlioz B; Kaseer HS; Sanghavi DK; Guru PK
    BMJ Case Rep; 2020 Jan; 13(1):. PubMed ID: 31915185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.